Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. O. Yildirim, M. Vandana, G. John, B. Müller, H. Fehrenbach (Munich, Marburg, , Borstel, Germany). LSC 2010 Abstract: New insights and therapeutically strategies for emphysema and COPD: The growth factors KGF and TGFβ-1. Eur Respir J 2010; 36: Suppl. 54, 210

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: New insights and therapeutically strategies for emphysema and COPD: the growth factors KGF and TGF?-1 Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 LSC 2011 Abstract: Suppression of antitumor immunity as a potential link between inflammation and cancer in COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011 Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights Source: Eur Respir J, 58 (2) 2100920; 10.1183/13993003.00920-2021 Year: 2021 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Transcription factors in asthma and COPD: a short overview Source: Annual Congress 2004 - Transcription factors in airway disease Year: 2004 Living well with pulmonary fibrosis: new insights Source: Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway Year: 2021 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 LSC 2010 Abstract: Bacterial-induced protection against asthma through a novel multi-component immunoregulatory mechanism Source: Annual Congress 2010 - Immune modulation of airways diseases Year: 2010 Live from London: Current and future biomarkers in severe asthma Source: ERS Satellite 2018 Year: 2018 Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Source: Eur Respir J 2002; 19: 1179-1193 Year: 2002 Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 LSC 2010 Abstract: Potential of ACE2 as a therapeutic target for pulmonary hypertension Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 IgE-mediated asthma: New revelations and future insights Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights Year: 2015 Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010 New mechanisms and targets in COPD Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014